IBDEI1PW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27443,1,3,0)
 ;;=3^Olanzapine,Long-Acting 1mg
 ;;^UTILITY(U,$J,358.3,27444,0)
 ;;=J1943^^112^1333^2^^^^1
 ;;^UTILITY(U,$J,358.3,27444,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27444,1,2,0)
 ;;=2^J1943
 ;;^UTILITY(U,$J,358.3,27444,1,3,0)
 ;;=3^Aristada Initio 1mg
 ;;^UTILITY(U,$J,358.3,27445,0)
 ;;=96156^^112^1334^1^^^^1
 ;;^UTILITY(U,$J,358.3,27445,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27445,1,2,0)
 ;;=2^96156
 ;;^UTILITY(U,$J,358.3,27445,1,3,0)
 ;;=3^Hlth/Behav,Assess/Reassess,Ea 15 min
 ;;^UTILITY(U,$J,358.3,27446,0)
 ;;=96158^^112^1334^2^^^^1
 ;;^UTILITY(U,$J,358.3,27446,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27446,1,2,0)
 ;;=2^96158
 ;;^UTILITY(U,$J,358.3,27446,1,3,0)
 ;;=3^Hlth/Behav Interv,Indiv,Init 30 min
 ;;^UTILITY(U,$J,358.3,27447,0)
 ;;=96159^^112^1334^3^^^^1
 ;;^UTILITY(U,$J,358.3,27447,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27447,1,2,0)
 ;;=2^96159
 ;;^UTILITY(U,$J,358.3,27447,1,3,0)
 ;;=3^Hlth/Behav Interv,Indiv,Ea Addl 15 min
 ;;^UTILITY(U,$J,358.3,27448,0)
 ;;=96164^^112^1334^4^^^^1
 ;;^UTILITY(U,$J,358.3,27448,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27448,1,2,0)
 ;;=2^96164
 ;;^UTILITY(U,$J,358.3,27448,1,3,0)
 ;;=3^Hlth/Behav Interv,Grp,Init 30 min
 ;;^UTILITY(U,$J,358.3,27449,0)
 ;;=96165^^112^1334^5^^^^1
 ;;^UTILITY(U,$J,358.3,27449,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27449,1,2,0)
 ;;=2^96165
 ;;^UTILITY(U,$J,358.3,27449,1,3,0)
 ;;=3^Hlth/Behav Interv,Grp,Ea Addl 15 min
 ;;^UTILITY(U,$J,358.3,27450,0)
 ;;=90471^^112^1335^1^^^^1
 ;;^UTILITY(U,$J,358.3,27450,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27450,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,27450,1,3,0)
 ;;=3^IMMUNIZATION ADMIN,1 INJECTION
 ;;^UTILITY(U,$J,358.3,27451,0)
 ;;=90472^^112^1335^2^^^^1
 ;;^UTILITY(U,$J,358.3,27451,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27451,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,27451,1,3,0)
 ;;=3^IMMUN ADMIN, EACH ADDITIONAL
 ;;^UTILITY(U,$J,358.3,27452,0)
 ;;=90732^^112^1336^29^^^^1
 ;;^UTILITY(U,$J,358.3,27452,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27452,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,27452,1,3,0)
 ;;=3^PNEUMOVAX 23 (PNEUMOCOCCAL VACCINE)
 ;;^UTILITY(U,$J,358.3,27453,0)
 ;;=90658^^112^1336^12^^^^1
 ;;^UTILITY(U,$J,358.3,27453,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27453,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,27453,1,3,0)
 ;;=3^FLU VACCINE MULTI DOSE VIAL (AFLURIA IIV3)
 ;;^UTILITY(U,$J,358.3,27454,0)
 ;;=90585^^112^1336^1^^^^1
 ;;^UTILITY(U,$J,358.3,27454,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27454,1,2,0)
 ;;=2^90585
 ;;^UTILITY(U,$J,358.3,27454,1,3,0)
 ;;=3^BCG VACCINE, PERCUT
 ;;^UTILITY(U,$J,358.3,27455,0)
 ;;=90632^^112^1336^17^^^^1
 ;;^UTILITY(U,$J,358.3,27455,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27455,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,27455,1,3,0)
 ;;=3^HEP A VACCINE, ADULT IM
 ;;^UTILITY(U,$J,358.3,27456,0)
 ;;=90636^^112^1336^18^^^^1
 ;;^UTILITY(U,$J,358.3,27456,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27456,1,2,0)
 ;;=2^90636
 ;;^UTILITY(U,$J,358.3,27456,1,3,0)
 ;;=3^HEP A/HEP B VACC, ADULT IM
 ;;^UTILITY(U,$J,358.3,27457,0)
 ;;=90647^^112^1336^21^^^^1
 ;;^UTILITY(U,$J,358.3,27457,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27457,1,2,0)
 ;;=2^90647
 ;;^UTILITY(U,$J,358.3,27457,1,3,0)
 ;;=3^HIB VACCINE, PRP-OMP, IM
 ;;^UTILITY(U,$J,358.3,27458,0)
 ;;=90648^^112^1336^22^^^^1
